Left Atrial Appendage Closure Devices Market Expected To Witness A Substantial Growth Of $5.7 Billion By 2030: Grand View Research Inc.



 The global left atrial appendage closure devices market size is expected to reach a value of USD 5.7 billion by 2030, registering a CAGR of 20.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of atrial fibrillation (AF) is expected to raise the left atrial appendage closure (LAAC) devices demand during the forecast period, which will further boost the market development.

The most prevalent arrhythmic condition in the world, AF affects more than 2.3 million individuals in the United States and 4.5 million in the European Union. With age, the incidence and disorder burden of AF increases, accounting for 15% of all strokes. The left atrial appendage (LAA) closure devices market has been greatly impacted by COVID-19. The pandemic prompted non-urgent operations, such as structural heart (SH) interventional surgery to be postponed or canceled, thereby, negatively impacting the market during 2020.

The COVID-19 outbreak had a temporary negative impact on product demand, significant delays in clinical trials, disrupted operations, and the market witnessed a detrimental effect on financial performance. For instance, AtriCure reported that its business was most impacted in the second, third, and fourth quarters of 2020, in terms of the decline in patients and revenue from the shelter-in-place restrictions in a majority of the countries and limitations on procedures in hospitals. However, the market witnessed growth from the third quarter of 2020, as patient procedure volume trends and availability of healthcare resources improved owing to a lift in certain restrictions.

The LAAC device industry is competitive and significantly affected by the new product introductions and other strategic activities of the industry participants. Market leaders are involved in the establishment of extensive distribution systems as well as increasingly engaged in mergers &acquisitions to capture a larger share of the market. For instance, in February 2022, Boston Scientific Corporation completed the acquisition of Baylis Medical Company Inc., a privately-held corporation that has developed the Versa Cross Transseptal Platforms including a family of sheaths, guidewires, and dilators used to support left heart access. Thus, expanded Boston Scientific Corporation’s electrophysiology and structural heart product portfolios.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/left-atrial-appendage-closure-laac-devices-market-report/request/rs1

There has been a considerable demand in the industry due to the rising prevalence of the atrial fibrillation, one of the most difficult conditions where appendage treatment is required. Increasing prevalence of the atrial fibrillation is credited to a high-calorie diet, smoking, and physical inactivity. The industry is witnessing strong demand, owing to the changes in lifestyle, better access to healthcare services, and rising geriatric population, prone to CVDs. Furthermore, electrophysiology procedures represent a significant opportunity to the market. Technological advancements in interventional treatments and improvements in the diagnosis pathway are the factors driving significant growth in the number of people treated with electrophysiology procedures. Effectiveness of the implants and procedural safety has greatly improved in developed as well as in developing country.

Left Atrial Appendage Closure Devices Market Report Highlights

  • Endocardial dominated the technique segment of the left atrial appendage closure (LAAC) devices market in 2021. Endocardial implants are considered to be easier for using. The availability of a wide range of products also contributes to segment growth
  • The epicardial segment is expected to grow at a lucrative rate during the forecast period. Epicardial procedures possess benefits over some endocardial device features. Anticoagulation is not necessary while using epicardial devices, not even immediately after the procedure
  • The hospital segment held the largest share of over 77% in 2021. Due to the increasing popularity of LAA surgeries and the growing acceptance of LAA closure devices in hospitals, they make up the largest end-use segment for the left atrial appendage closure devices
  • Asia Pacific region is anticipated to register rapid growth in coming years owing to the presence of high unmet needs coupled with increasing patient awareness levels and improving healthcare infrastructure
  • Growing R&D investments by the key companies and geographic expansion, as well as an increase in product portfolios, are the factors expected to contribute to the market growth. In August 2021, Abbott has received U.S. FDA approval for its Amplatzer Amulet LAA Occluder to treat individuals with atrial fibrillation

The market for left atrial appendage closure (LAAC) devices has been greatly impacted by the COVID-19 outbreak. The pandemic and the measures put in place to manage it have negatively impacted on the company’s operations and financial position. Hospitals, ambulatory surgery centers, and other treatment facilities reduced many elective procedures, resulting in a significantly reduced procedure volume. Moreover, non-urgent operations such as structural heart interventional surgeries were cancelled.

As per the study published in National Library of Medicine, the number of cardiac surgeries performed in England during the COVID-19 pandemic has decreased dramatically, by over 45,000 procedures, without an increase in the mortality risk for the majority of these treatments.

However, market players saw a sharp rebound in 2021, with sales across business segments higher than during the pandemic. Boston Scientifics’ revenue grew above 19% to $11.88 billion in 2021 during the last twelve months. The increase in revenue was primarily led by the higher sales for its Interventional Cardiology, Electrophysiology, and Urology as well as Pelvic Health. Due to increased physician utilization, its left atrial appendage (LAA) closure device, Watchman, has gained market share, thus strengthening its overall revenue growth.

List of Key Players in the Left Atrial Appendage Closure (LAAC) Devices Market

  • Boston Scientific Corporation
  • Abbott
  • AtriCureInc.
  • Life tech Scientific
  • Cardia, Inc.
  • Lepu Medical Technology (Beijing) Co. Ltd.
Johnson & Johnson (Biosense Webster, Inc.)

Comments

Post a Comment

Popular posts from this blog

Vertical Farming Market Growth On The Basis Of Type, Application, Region & Forecast To 2030: Grand View Research Inc.

Image
  The vertical farming market is witnessing significant advancements, marked by the adoption of innovative technologies, including sensors and cameras, to increase yields and enhance resource efficiency. Vertical farming efficiently addresses the challenges of limited space and environmental constraints. It offers a reliable solution by ensuring stable crop production, even during unfavorable weather conditions. Compared to traditional farming methods, vertical farming provides numerous advantages, including reduced water usage, decreased reliance on agrochemicals, and decreased dependency on agricultural labor. As a result, vertical farming is emerging as a promising alternative to meet the growing needs of urban populations. The ABCs of Vertical Farming: Key Components ·          Hardware: Vertical farming relies on various hardware components and systems to create the ideal environment for plants to grow optimally. The hardware components include: o    Lighting: Lighting in
Read more

Clinical Diagnostics Market Segment Analysis By Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

Image
  San Francisco, 12 June 2024:  The Report Clinical Diagnostics Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025 The clinical diagnostics market, like many other businesses, is entering the Industry 4.0 revolution. The advent of digitalization, automation, and robotization has helped develop highly flexible smart laboratories. These labs can manage both high-volume/routine analyses and highly customized analyses at reasonable prices. Clinical laboratories are required to have exceptional flexibility to adapt quickly to persistent shifts and unpredictable new environments. Mentioned below are the 5 key trends that are helping the clinical diagnostics industry survive in a dynamic environment: Integration of Automation Technologies in Genomics Over the years, the accuracy of genome sequencing has radically improved. Furthermore, sequencing and library preparation platforms are n
Read more

Satellite Payload Market Growth On The Basis Of Type, Application, Region & Forecast To 2025: Grand View Research Inc.

  San Francisco, 10 June 2024:  The Report Satellite Payloads Market Size, Share & Trends Analysis Report By Orbit (LEO, MEO, GEO), By Application (Communication & Navigation, Remote Sensing, Surveillance), By End Use, By Region, And Segment Forecasts, 2018 - 2025 The global satellite payloads market size is expected to reach USD 21.8 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 7.9% over the forecast period, owing to Increased government spending in space exploration activities is expected to boost the market growth over the forecast period. The growing popularity of communication and broadcasting services including pay TV and Over-The-Top (OTT) have led providers to develop advanced payload systems. Moreover, the increased penetration of payloads in the commercial sector is expected to propel the market demand. The market is expected to witness significant growth as there has been a great rise in t
Read more